Immunophage Biotech is a pharmaceutical company based in China that specializes in the research and development of innovative medicines for the treatment of cancer, autoimmune diseases, and neurodegenerative disorders. The company was founded in 2016 and has its R&D center located in the Pujiang High-Tech Park in Shanghai. Their focus is on creating groundbreaking immune-regulating therapies that can improve patient outcomes.

Disease Domain	Count

Immune System Diseases	13
Nervous System Diseases	12
Neoplasms	8
Endocrinology and Metabolic Disease	6
Hemic and Lymphatic Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	11
Monoclonal antibody	6
Antibody	2
Chemical drugs	1

Top 5 Target	Count

GPR183(G protein-coupled receptor 183)	4
CCR8(C-C motif chemokine receptor 8)	3
CD38(Lymphocyte differentiation antigen CD38)	2
CD38 x Hydrolase x NAD+	1
GPR17(G protein-coupled receptor 17)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 04 Aug 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

IND Application

Phase 1

Phase 2

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

IPG-1094 ( MIF )	Lupus Nephritis More	Phase 2
IPG-11406 ( GPR183 )	Lupus Nephritis More	Phase 2
IPG-7236 ( CCR8 )	Advanced Malignant Solid Neoplasm More	Phase 1/2
IPG-8294 ( CD38 x Hydrolase x NAD+ )	Alzheimer Disease More	Phase 1
IPG0521 ( CCR8 )	Solid tumor More	IND Application

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis